Melanoma differentiation associated gene-7/interleukin-24 (mda-7/IL-24): Novel gene therapeutic for metastatic melanoma
- 1 November 2007
- journal article
- review article
- Published by Elsevier in Toxicology and Applied Pharmacology
- Vol. 224 (3) , 300-307
- https://doi.org/10.1016/j.taap.2006.11.021
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Cytokine-Based Therapy and Biochemotherapy for Advanced MelanomaClinical Cancer Research, 2006
- MDA-7/IL-24: novel cancer growth suppressing and apoptosis inducing cytokineCytokine & Growth Factor Reviews, 2002
- mda- 7 (IL-24) mediates selective apoptosis in human melanoma cells by inducing the coordinated overexpression of the GADD family of genes by means of p38 MAPKProceedings of the National Academy of Sciences, 2002
- The Protein Product of the Tumor Suppressor Gene, Melanoma Differentiation-Associated Gene 7, Exhibits Immunostimulatory Activity and Is Designated IL-24The Journal of Immunology, 2002
- Loss of MDA-7 expression with progression of melanoma.2002
- The cancer growth suppressing gene mda-7 induces apoptosis selectively in human melanoma cellsOncogene, 2002
- mda-5: An interferon-inducible putative RNA helicase with double-stranded RNA-dependent ATPase activity and melanoma growth-suppressive propertiesProceedings of the National Academy of Sciences, 2002
- Down-regulated melanoma differentiation associated gene (mda-7) expression in human melanomasInternational Journal of Cancer, 2001
- Differentiation therapy of human cancer: basic science and clinical applicationsPharmacology & Therapeutics, 2001
- RaSH, a rapid subtraction hybridization approach for identifying and cloning differentially expressed genesProceedings of the National Academy of Sciences, 2000